Caspofungin-Mepha 50 mg
Caspofungin-Mepha 50 mg is a medicine authorised by Swissmedic under authorisation number 67231. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 08 March 2019 and the authorisation is valid without a time limit. ATC code J02AX04 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 67231 |
|---|---|
| Name | Caspofungin-Mepha 50 mg |
| Full name | Caspofungin-Mepha 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J02AX04 |
| First authorisation | 08 March 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Caspofungin-Mepha 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 08 March 2019 |
| 2 | Caspofungin-Mepha 70 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 08 March 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J02AX04 | 08.06.0. | A |
| 2 | 1 | Durchstechflasche(n) | J02AX04 | 08.06.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Caspofungin-Mepha 50 mg authorised in Switzerland?
Yes. Caspofungin-Mepha 50 mg is authorised by Swissmedic under authorisation number 67231, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Caspofungin-Mepha 50 mg have?
Caspofungin-Mepha 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Caspofungin-Mepha 50 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.